Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in

CNS IDH-mutant and 1p/19q-codeleted PMS2 lynch syndrome oligodendroglioma

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 27 05 2022
accepted: 30 06 2022
entrez: 19 8 2022
pubmed: 20 8 2022
medline: 20 8 2022
Statut: epublish

Résumé

Most tumors, including brain tumors, are sporadic. However, a small subset of CNS tumors are associated with hereditary cancer conditions like Lynch Syndrome (LS). Here, we present a case of an oligodendroglioma, IDH-mutant and 1p/19q-codeleted, and LS with a germline pathogenic

Identifiants

pubmed: 35982947
doi: 10.3389/fonc.2022.954879
pmc: PMC9379095
doi:

Types de publication

Case Reports

Langues

eng

Pagination

954879

Informations de copyright

Copyright © 2022 Merchant, Raygada, Pang, Quezado, Raffeld, Xi, Kim, Tyagi, Abdullaev, Kim, Sergi, Pillai, Ozer, Zaghloul, Heiss, Armstrong, Gilbert, Aldape and Wu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Natl Cancer Inst. 2006 Mar 1;98(5):358-61
pubmed: 16507833
Int J Cancer. 1996 Feb 8;65(4):422-5
pubmed: 8621220
Gastroenterology. 2015 Sep;149(3):604-13.e20
pubmed: 25980754
BMC Med Genet. 2017 Apr 5;18(1):40
pubmed: 28381238
J Clin Oncol. 2015 Feb 1;33(4):319-25
pubmed: 25512458
Eur J Hum Genet. 2008 Jan;16(1):62-72
pubmed: 17851451
Fam Cancer. 2005;4(3):245-8
pubmed: 16136385
Genet Med. 2016 Jan;18(1):13-9
pubmed: 25856668
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Oncogene. 2000 Mar 23;19(13):1719-23
pubmed: 10763829
Gastroenterology. 2006 Mar;130(3):665-71
pubmed: 16530507
J Med Genet. 2014 Jun;51(6):355-65
pubmed: 24737826
Am J Gastroenterol. 2005 Aug;100(8):1886-91
pubmed: 16144131
Eur J Neurol. 2015 Apr;22(4):717-24
pubmed: 25648859
Hered Cancer Clin Pract. 2010 May 21;8(1):5
pubmed: 20487569
J Med Genet. 2020 Jul;57(7):487-499
pubmed: 31992580
Genet Med. 2016 Oct;18(10):974-81
pubmed: 26845104
Lancet Oncol. 2009 Apr;10(4):400-8
pubmed: 19341971
Int J Cancer. 1999 Apr 12;81(2):214-8
pubmed: 10188721
Gastroenterology. 2008 Aug;135(2):419-28
pubmed: 18602922
J Med Genet. 1999 Nov;36(11):801-18
pubmed: 10544223
Fam Cancer. 2019 Apr;18(2):261-265
pubmed: 30478739
Nat Commun. 2017 May 03;8:14755
pubmed: 28466842
Neuro Oncol. 2021 Oct 5;23(12 Suppl 2):iii1-iii105
pubmed: 34608945

Auteurs

Mythili Merchant (M)

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Margarita Raygada (M)

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Ying Pang (Y)

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Martha Quezado (M)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Mark Raffeld (M)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Liqiang Xi (L)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Jung Kim (J)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Manoj Tyagi (M)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Zied Abdullaev (Z)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Olga Kim (O)

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Zach Sergi (Z)

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Tina Pillai (T)

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Byram Ozer (B)

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Kareem Zaghloul (K)

Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD, United States.

John D Heiss (JD)

Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD, United States.

Terri S Armstrong (TS)

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Mark R Gilbert (MR)

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Kenneth Aldape (K)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Jing Wu (J)

Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Classifications MeSH